Ran Reshef
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 115
- Hematopoietic Stem Cell Transplantation 101
- Multiple Myeloma Research and Treatments 13
- Acute Myeloid Leukemia Research 5
- Oncology 71
- CAR-T cell therapy research 49
- Viral-associated cancers and disorders 22
- Co-authors
- David Porter (19 shared papers)Edward Allen Stadtmauer (26 shared papers)Daniel F. Heitjan (9 shared papers)Robert H. Vonderheide (20 shared papers)Elizabeth Olson Hexner (24 shared papers)Donald Edward Tsai (14 shared papers)Marlise Rachael Luskin (8 shared papers)Noelle V. Frey (22 shared papers)
- Journals
- Transplantation and Cellular Therapy (53 papers)Blood (40 papers)Blood Advances (17 papers)Journal of Clinical Oncology (9 papers)Bone Marrow Transplantation (9 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Ran Reshef
190 papers receiving 6.7k citations
Ran Reshef's Hit Papers
Peers
Comparison fields: 5 of 94
- Hematology 3.9k
- Oncology 1.6k
- Transplantation 88
- Pathology and Forensic Medicine 372
- Immunology 371
Countries citing papers authored by Ran Reshef
This map shows the geographic impact of Ran Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Reshef more than expected).
Fields of papers citing papers by Ran Reshef
This network shows the impact of papers produced by Ran Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Reshef. The network helps show where Ran Reshef may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Reshef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium Hit paper breakdown → | 2015 | 719 |
| 2 | Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2021 | 515 |
| 3 | Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis Hit paper breakdown → | 2023 | 400 |
| 4 | 2016 | 277 | |
| 5 | 2017 | 260 | |
| 6 | 2019 | 231 | |
| 7 | 2012 | 213 | |
| 8 | 2017 | 183 | |
| 9 | 2011 | 181 | |
| 10 | 2018 | 169 | |
| 11 | 2018 | 165 | |
| 12 | 2015 | 138 | |
| 13 | 2021 | 134 | |
| 14 | 2023 | 113 | |
| 15 | 2017 | 108 | |
| 16 | Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma Hit paper breakdown → | 2024 | 93 |
| 17 | 2019 | 87 | |
| 18 | 2020 | 84 | |
| 19 | 2018 | 75 | |
| 20 | 2020 | 67 |
About Ran Reshef
Ran Reshef is a scholar working on Hematology, Oncology, Immunology, Genetics and Physiology, having authored 205 papers that have together received 6.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (101 papers), CAR-T cell therapy research (49 papers), Viral-associated cancers and disorders (22 papers), Multiple Myeloma Research and Treatments (13 papers), T-cell and B-cell Immunology (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Acute Myeloid Leukemia Research (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (3.9k citations), Oncology (1.6k citations), Transplantation (88 citations), Pathology and Forensic Medicine (372 citations) and Immunology (371 citations). Ran Reshef has collaborated with scholars based in United States, Germany and France. Frequent co-authors include David Porter, Edward Allen Stadtmauer, Daniel F. Heitjan, Robert H. Vonderheide, Elizabeth Olson Hexner, Donald Edward Tsai, Marlise Rachael Luskin, Noelle V. Frey, Alison Wakoff Loren and Selina M. Luger. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Advances, Journal of Clinical Oncology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.